Unedited, unfiltered – the ‘hey, look at me!’ pink elephant really was this lurid!

It’s time for our second Preview from the World Congress in Lung Cancer being presented in Singapore next month.

In this edition we’re going to focus on the next raft of antibody drug conjugates (ADCs) coming through in early development.

Do any stand out as the next big kahuna or are the numbers too glaringly garish, waiting to be knocked off their coconut shies?

In this review we review the evidence and take some stands…

To continue reading our latest highlights on oncology new product development including commentary and analysis, BSB subscribers can log-in or you can click to access the content.

This content is restricted to subscribers

Posted by